Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years

Conclusions:
The high rates of change of both glutamate and glutamine over two years suggest they are promising new biomarkers of MS disease progression.

Source: Multiple Sclerosis - December 18, 2015 Category: Neurology Authors: MacMillan, E., Tam, R., Zhao, Y., Vavasour, I., Li, D., Oger, J., Freedman, M., Kolind, S., Traboulsee, A. Tags: Short Reports Source Type: research